Fortress Biotech, Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Accounts Payable and Accrued Expenses (Tables)

Accounts Payable and Accrued Expenses (Tables)

12 Months Ended

Dec. 31, 2023

Accounts Payable and Accrued Expenses

Schedule of accounts payable and accrued expenses

Accounts payable and accrued expenses consisted of the following:


		December 31,
($ in thousands)		2023			2022

Accounts payable		$	34,810		$	57,244
Accrued expenses:
Professional fees			1,681			1,693
Salaries, bonus and related benefits			8,531			9,772
Research and development			11,644			7,390
Research and development - license maintenance fees			—			632
Research and development - milestones			—			4,600
Accrued royalties payable			2,015			2,627
Accrued coupon and rebates			9,987			7,604
Return reserve			4,077			3,689
Accrued interest			—			342
Other			817			1,853
Total accounts payable and accrued expenses		$	73,562		$	97,446